Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

  • Showing results for a modified search because your search retrieved no results.
1.

Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.

Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Boustany-Kari CM, Devalaraja-Narashimha K, Morton L, Mottl AK, Patel U, Palmer M, Ross MJ, Sarov-Blat L, Steinbugler K, Susztak K; TRIDENT Study Investigators.

Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020. No abstract available.

PMID:
31901339
2.

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ.

PLoS Med. 2019 Mar 13;16(3):e1002763. doi: 10.1371/journal.pmed.1002763. eCollection 2019 Mar.

3.

The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.

Djukanovic R, Adcock IM, Anderson G, Bel EH, Canonica GW, Cao H, Chung KF, Davies DE, Genton C, Gibson-Latimer T, Hamerlijnck D, Heuvelin E, Louis R, Korn S, Kots M, Kwon N, Naddaf R, Wagers SS; SHARP Clinical Research Collaboration; Members of the CRC-SHARP.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801671. doi: 10.1183/13993003.01671-2018. Print 2018 Nov. No abstract available.

PMID:
30498052
4.

Enhancing the Value of the ASCO Value Framework.

Morton A, Bach PB, Briggs A.

MDM Policy Pract. 2018 May 29;3(1):2381468318776223. doi: 10.1177/2381468318776223. eCollection 2018 Jan-Jun. No abstract available.

5.

Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study.

Lerche S, Wurster I, Röben B, Machetanz G, Zimmermann M, Bernhard F, Stransky E, Deuschle C, Schulte C, Hansson O, Zetterberg H, Gasser T, Berg D, Maetzler W, Brockmann K.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):165-170. doi: 10.1136/jnnp-2018-318956. Epub 2018 Sep 25.

PMID:
30254084
6.

Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).

Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J.

Health Technol Assess. 2018 Jun;22(35):1-304. doi: 10.3310/hta22350.

7.

The Impact of Brexit on Pharmaceuticals and HTA.

Lorgelly PK.

Pharmacoecon Open. 2018 Jun;2(2):87-91. doi: 10.1007/s41669-018-0072-5. No abstract available.

8.

Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.

Jain R, Fu AC, Lim J, Wang C, Elder J, Sander SD, Tan H.

J Manag Care Spec Pharm. 2018 Jan;24(1):73-82. doi: 10.18553/jmcp.2018.24.1.73.

10.

Receptor tyrosine kinase KIT: Prognostic and therapeutic involvement in canine mast cell tumours.

Takeuchi Y, Bonkobara M.

Vet J. 2016 Apr;210:5-6. doi: 10.1016/j.tvjl.2015.07.012. Epub 2015 Jul 29. No abstract available.

PMID:
26896296
12.

Battlefield medicine: paradigm shift for pharmaceuticals manufacturing.

Choi EJ, Ling GS.

PDA J Pharm Sci Technol. 2014 Jul-Aug;68(4):312. doi: 10.5731/pdajpst.2014.01002. No abstract available.

PMID:
25035252
13.

Intelligent pharmaceuticals: beyond the tipping point.

Honig P, Huang SM.

Clin Pharmacol Ther. 2014 May;95(5):455-9. doi: 10.1038/clpt.2014.32.

PMID:
24747228
14.

Detecting adverse drug reactions - a concise updateI. Cohort and case control studies.

Lawson DH.

Int J Risk Saf Med. 1991;2(1):39-44. doi: 10.3233/JRS-1991-2106.

PMID:
23511814

Supplemental Content

Loading ...
Support Center